1. | To develop guidelines for PMCs |
2. | To provide evidence that patient education and counseling in PMCs are valuable in the following viewpoints: |
a. adherence to pharmacotherapy | |
b. knowledge about pharmacotherapy | |
c. clinical outcome | |
d. cost-effectiveness | |
3. | Outreach activity for PMCs |